[Prognostic factors of ovarian cancer].
Consequent surgery and new cytostatic agents have improved the prognosis of advanced ovarian carcinoma. Relevant parameters would appear to be the FIGO staging and the size of the post-operative residual tumor. The age and response to chemotherapy are of subordinate importance. A clinical remission depends on the general condition, type of chemotherapy, and the differentiating degree of the tumor.
D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D002277:Carcinoma / Q000473:pathology*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D009368:Neoplasm Transplantation; D010051:Ovarian Neoplasms / Q000473:pathology* / Q000601:surgery; D010053:Ovary / Q000473:pathology; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D014410:Tumor Stem Cell Assay
D000951:Antigens, Neoplasm; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone
Prognosefaktoren des Ovarialkarzinoms.